Bringing together clinicians, researchers, government and industry to deliver genomic cancer medicine clinical trials to Australians with rare, less common and early-onset cancers
Providing support and advocacy for patients. With Rare Cancer Australia we support patients making decisions about participating in an AGCMC Program. This includes support in the form of telephone support, transport and accommodation for people on trials. Together we develop information and other materials for patients and carers, and advocate for these patients and their priorities.
The Australian Genomic Cancer Medicine Program, an innovative program of screening and clinical trials for people with rare and uncommon cancers, will receive $50 million in Australian Government funding over five years to expand nationally.
An innovative suite of clinical trials, matching therapies with individuals on the basis of genetic information, could one day hold the key to rare and uncommon cancers and give hope to patients who have exhausted other treatment options.
Neglected Cancers Awareness Week - an important week where we call on government, corporations, and the community at large to place a greater focus on less common, but high-mortality cancers – the ‘neglected’ cancers.